Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of oseltamivir oral suspension versus Tamiflu in healthy Thai adults under fasting conditions
TCTR20260904006Phase 1Not yet recruiting
- Sponsor
- Dr. Sasitorn Kittivoravitkul
- Start
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oseltamivir in Influenza A infection and influenza B (2 arms), sponsored by Dr. Sasitorn Kittivoravitkul. Primary endpoints: Maximum plasma concentration of oseltamivir, Area under the plasma concentration-time curve from dosing to last observed concentration and 2 more. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
oseltamivir
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on TCTR20260904006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260904006.